| scholarly article | Q13442814 |
| P2093 | author name string | Michael Wang | |
| Robert L Garcea | |||
| Suchitra Rao | |||
| Jaime M Kean | |||
| P2860 | cites work | Identification of a novel polyomavirus from patients with acute respiratory tract infections | Q21131611 |
| T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus | Q24645091 | ||
| Clonal integration of a polyomavirus in human Merkel cell carcinoma | Q24657675 | ||
| Identification of a third human polyomavirus | Q24672044 | ||
| New human papovavirus (B.K.) isolated from urine after renal transplantation | Q28236639 | ||
| Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays | Q33186315 | ||
| WU polyomavirus in children with acute lower respiratory tract infections, South Korea | Q33883958 | ||
| Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus | Q33964857 | ||
| Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
| Simian virus 40 in human cancers | Q34204711 | ||
| Serological cross reactivity between polyomavirus capsids | Q34515365 | ||
| A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children | Q34664452 | ||
| Age-related pattern of KI and WU polyomavirus infection | Q34788391 | ||
| Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). | Q36454135 | ||
| Ependymomas produced after Intracerebral Inoculation of SV40 into New-born Hamsters | Q51293887 | ||
| Genome structure and host range restriction of the lymphotropic papovavirus (LPV): identification of a viral lymphocyte specific enhancer element. | Q53556566 | ||
| [Discovery and identification of WU polyomavirus in children from Zhejing region]. | Q54543516 | ||
| MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. | Q55050206 | ||
| [WU polyomavirus and KI polyomavirus detected in specimens from children with acute respiratory tract infection in China] | Q64126868 | ||
| The epidemiology of human polyomaviruses | Q64944287 | ||
| Seroepidemiology of the human polyomaviruses | Q73445171 | ||
| Serological diagnosis of human polyomavirus infection | Q36454149 | ||
| Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors | Q36956860 | ||
| Emerging respiratory agents: new viruses for old diseases? | Q37136318 | ||
| First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies | Q39761976 | ||
| Fast and high-affinity binding of B-lymphotropic papovavirus to human B-lymphoma cell lines | Q39872283 | ||
| Evidence of chronic persistent infections with polyomaviruses (BK type) in renal transplant recipients | Q39940697 | ||
| BK virus: I. Seroepidemiologic studies and serologic response to viral infection | Q40161398 | ||
| Lymphotropic papovaviruses isolated from African green monkey and human cells | Q40261864 | ||
| WU polyomavirus in children, Canada | Q40761615 | ||
| Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. | Q41991356 | ||
| WU polyomavirus infection in children, Germany | Q43252735 | ||
| A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology | Q43625138 | ||
| SV40-induced ependymomas in newborn hamsters. I. Virus-tumor relationships | Q44105189 | ||
| HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase | Q44170300 | ||
| A new monkey lymphotropic papovavirus: characterization of the virus and evidence of a related virus in humans | Q45798377 | ||
| Naturally occurring and passage-induced variation in the genome of JC virus | Q45798378 | ||
| Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients | Q45803916 | ||
| Host range restriction of the lymphotropic papova virus (LPV) in cells of human hematopoietic origin. | Q45841803 | ||
| WU and KI polyomavirus present in the respiratory tract of children, but not in immunocompetent adults | Q47348468 | ||
| Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. | Q47763052 | ||
| Prevalence and molecular characterization of WU/KI polyomaviruses isolated from pediatric patients with respiratory disease in Thailand. | Q48074835 | ||
| WU polyomavirus in children with acute lower respiratory tract infections, China | Q48075212 | ||
| Presence of the newly discovered human polyomaviruses KI and WU in Australian patients with acute respiratory tract infection. | Q48075908 | ||
| SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice | Q48467800 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Polyomavirus | Q1648694 |
| seroepidemiology | Q130270551 | ||
| P304 | page(s) | e1000363 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Seroepidemiology of human polyomaviruses | |
| P478 | volume | 5 |
| Q34332024 | A cornucopia of human polyomaviruses |
| Q34163596 | A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus |
| Q37410710 | A novel picornavirus associated with gastroenteritis |
| Q45357575 | A peptide talk between JC virus and the human host: from silent infection to autoimmunity. |
| Q92794051 | A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses |
| Q37482476 | A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses |
| Q36301133 | A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replication |
| Q34215433 | A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient. |
| Q37550569 | Activation of PI3K signaling in Merkel cell carcinoma |
| Q34205870 | Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer |
| Q39587782 | Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells. |
| Q36002505 | Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice. |
| Q30497882 | African great apes are naturally infected with polyomaviruses closely related to Merkel cell polyomavirus |
| Q38627474 | Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus |
| Q34321814 | Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus |
| Q34283583 | Agnoprotein of mammalian polyomaviruses |
| Q36953496 | An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects. |
| Q45352744 | An assay to quantify species-specific anti-JC virus antibody levels in MS patients |
| Q38846030 | Anion homeostasis is important for non-lytic release of BK polyomavirus from infected cells |
| Q42214743 | Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial |
| Q40565210 | Anti-JC virus seroprevalence in a Finnish MS cohort. |
| Q45361114 | Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. |
| Q40720491 | Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects |
| Q34325718 | Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection |
| Q34267871 | Antibodies to Merkel Cell Polyomavirus T Antigen Oncoproteins Reflect Tumor Burden in Merkel Cell Carcinoma Patients |
| Q50995643 | Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection. |
| Q35742569 | Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer. |
| Q47554034 | Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement |
| Q84357905 | Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation |
| Q45323585 | Antiviral treatment of BK virus viremia after kidney transplantation |
| Q38216925 | Are human polyomaviruses co-factors for cancers induced by other oncoviruses? |
| Q92557659 | Association Between Simian Virus 40 and Human Tumors |
| Q24644897 | Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma |
| Q36053618 | Asymptomatic primary Merkel cell polyomavirus infection among adults. |
| Q59352951 | BK Polyomavirus MicroRNA Levels in Exosomes Are Modulated by Non-Coding Control Region Activity and Down-Regulate Viral Replication When Delivered to Non-Infected Cells Prior to Infection |
| Q40281578 | BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study |
| Q38570451 | BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment |
| Q90022401 | BK polyomavirus diversity-Why viral variation matters |
| Q35006676 | BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition. |
| Q36202667 | BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients |
| Q27468945 | BK virus encephalopathy and sclerosing vasculopathy in a patient with hypohidrotic ectodermal dysplasia and immunodeficiency |
| Q45368523 | BK virus-associated infection in cerebrospinal fluid of neurological patients and mutation analysis of the complete VP1 gene in different patient groups |
| Q94571349 | BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation |
| Q34023561 | BKV agnoprotein interacts with α-soluble N-ethylmaleimide-sensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP. |
| Q47166144 | Biology of the BKPyV: An Update |
| Q58106789 | CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infection |
| Q38792000 | Caveolin- and clathrin-independent entry of BKPyV into primary human proximal tubule epithelial cells |
| Q21560943 | Cellular and viral factors regulating Merkel cell polyomavirus replication |
| Q33679931 | Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation |
| Q34483309 | Characterization of T Antigens, Including Middle T and Alternative T, Expressed by the Human Polyomavirus Associated with Trichodysplasia Spinulosa. |
| Q35073596 | Characterization of self-assembled virus-like particles of Merkel cell polyomavirus |
| Q54317684 | Common WU polyomavirus infection in a Beijing population indicated by surveillance for serum IgG antibody against capsid protein VP2. |
| Q34259801 | Common exposure to STL polyomavirus during childhood |
| Q39662439 | Common infections with polyomaviruses and herpesviruses and neuropsychological development at 4 years of age, the Rhea birth cohort in Crete, Greece |
| Q99241096 | Comparative Evaluation of In-House and Commercial Real-Time PCR Methods for the Detection of the BK and JC Viruses in Clinical Samples |
| Q39162526 | Comparing effects of BK virus agnoprotein and herpes simplex-1 ICP47 on MHC-I and MHC-II expression. |
| Q41724907 | Complete genomic sequence of a new Human polyomavirus 9 strain with an altered noncoding control region. |
| Q41548443 | Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients |
| Q27682301 | Crystallographic and Glycan Microarray Analysis of Human Polyomavirus 9 VP1 Identifies N-Glycolyl Neuraminic Acid as a Receptor Candidate |
| Q38843499 | Current status of pediatric renal transplant pathology |
| Q33547027 | Demyelinating disorders |
| Q64083377 | Detection and genome characterization of two novel papillomaviruses and a novel polyomavirus in tree shrew (Tupaia belangeri chinensis) in China |
| Q38691462 | Detection and quantification of Merkel cell polyomavirus. Analysis of Merkel cell carcinoma cases from 1977 to 2015. |
| Q36991114 | Detection of Malawi polyomavirus sequences in secondary lymphoid tissues from Italian healthy children: a transient site of infection |
| Q44206123 | Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms. |
| Q42283853 | Detection of Merkel cell polyomavirus in oral samples of renal transplant recipients without Merkel cell carcinoma. |
| Q54369045 | Detection of Merkel cell polyomavirus on environmental surfaces. |
| Q47228508 | Development and evaluation of a broad bead-based multiplex immunoassay to measure IgG seroreactivity against human polyomaviruses. |
| Q34388047 | Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. |
| Q36131702 | Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members |
| Q21090503 | Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient |
| Q21560740 | Discovery of a novel polyomavirus in acute diarrheal samples from children |
| Q36568645 | Disease-modifying therapy of pediatric multiple sclerosis |
| Q38926133 | Distinct BK polyomavirus non-coding control region (NCCR) variants in oral fluids of HIV- associated Salivary Gland Disease patients |
| Q33701787 | Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma |
| Q54304435 | Dynamics of pregnancy-associated polyomavirus urinary excretion: a prospective longitudinal study. |
| Q33567194 | Dynamics of urinary polyomavirus shedding in healthy adult women |
| Q47555780 | ERK is a Critical Regulator of JC Polyomavirus Infection |
| Q92559982 | Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor |
| Q40780033 | Ecology of Merkel Cell Polyomavirus in Healthy Skin Among Individuals in an Asian Cohort |
| Q92596472 | Effect of the Large and Small T-Antigens of Human Polyomaviruses on Signaling Pathways |
| Q90286881 | Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS |
| Q45157613 | Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine |
| Q35645258 | Efficient propagation of archetype BK and JC polyomaviruses |
| Q35798482 | Endemic Viruses of Squirrel Monkeys (Saimiri spp.). |
| Q34364604 | Entry tropism of BK and Merkel cell polyomaviruses in cell culture |
| Q39126203 | Entry, infection, replication, and egress of human polyomaviruses: an update |
| Q36456766 | Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas |
| Q45375399 | Evaluation of a BK virus real-time PCR assay designed using novel bioinformatics technology |
| Q36652838 | Exposure to raccoon polyomavirus (RacPyV) in free-ranging North American raccoons (Procyon lotor). |
| Q35048631 | Fanconi anemia patients are more susceptible to infection with tumor virus SV40 |
| Q33609269 | Fecal Polyomavirus Excretion in Infancy. |
| Q36716329 | Frequent detection of Merkel cell polyomavirus DNA in sera of HIV-1-positive patients |
| Q37946371 | From orphan virus to pathogen: the path to the clinical lab. |
| Q38981709 | Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection |
| Q35382791 | Gamma interferon controls mouse polyomavirus infection in vivo |
| Q39824959 | Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus |
| Q33827126 | Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies |
| Q83462176 | Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma |
| Q100533934 | Genome-wide profiling of BK polyomavirus integration in bladder cancer of kidney transplant recipients reveals mechanisms of the integration at the nucleotide level |
| Q55432495 | HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment. |
| Q39707878 | High detection rates of nucleic acids of a wide range of respiratory viruses in the nasopharynx and the middle ear of children with a history of recurrent acute otitis media. |
| Q33636869 | High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors |
| Q36397962 | High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma. |
| Q64105123 | High-Throughput Characterization of Viral and Cellular Protein Expression Patterns During JC Polyomavirus Infection |
| Q93117453 | High-Throughput Sequencing-Based Investigation of Viruses in Human Cancers by Multienrichment Approach |
| Q27468807 | How Polyomaviruses Exploit the ERAD Machinery to Cause Infection |
| Q40655855 | How to Improve the Positive Predictive Value of Urinary Decoy Cell Surveillance for Polyomavirus BK-Associated Nephropathy in Kidney Transplant Patients |
| Q92477903 | Human BK and JC polyomaviruses: Molecular insights and prevalence in Asia |
| Q92128486 | Human DNA Virus Exploitation of the MAPK-ERK Cascade |
| Q38115562 | Human Merkel cell polyomavirus: virological background and clinical implications |
| Q37361949 | Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study |
| Q33678538 | Human polyomavirus 9 infection in kidney transplant patients |
| Q61450444 | Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence |
| Q36234246 | Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment |
| Q34544410 | Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma |
| Q21285083 | Human polyomavirus reactivation: disease pathogenesis and treatment approaches |
| Q35931809 | Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. |
| Q36053656 | Human polyomavirus related to African green monkey lymphotropic polyomavirus |
| Q36159241 | Human polyomavirus type six in respiratory samples from hospitalized children with respiratory tract infections in Beijing, China |
| Q57475455 | Human polyomaviruses and cancer: an overview |
| Q34324891 | Human polyomaviruses in disease and cancer |
| Q30407393 | Human polyomaviruses in skin diseases |
| Q37525735 | Identification and Characterization of Novel Rat Polyomavirus 2 in a Colony of X-SCID Rats by P-PIT assay |
| Q40080609 | Identification of Rab18 as an Essential Host Factor for BK Polyomavirus Infection Using a Whole-Genome RNA Interference Screen. |
| Q21559678 | Identification of a novel human polyomavirus in organs of the gastrointestinal tract |
| Q35220082 | Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops |
| Q36989398 | Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection |
| Q33915258 | Immune response to JC virus T antigen in patients with and without colorectal neoplasia |
| Q37678580 | Immune surveillance and response to JC virus infection and PML. |
| Q37939726 | Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer. |
| Q34624353 | Immunohistochemical detection of KI polyomavirus in lung and spleen. |
| Q41069112 | Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40. |
| Q34818048 | Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab |
| Q38025665 | Immunotherapy for polyomaviruses: opportunities and challenges |
| Q38736149 | Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region |
| Q47147327 | Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses |
| Q52728829 | Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. |
| Q82268960 | Inflammatory monocytes are a reservoir for Merkel cell polyomavirus |
| Q37411994 | Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9 |
| Q27681947 | Insights into the initiation of JC virus DNA replication derived from the crystal structure of the T-antigen origin binding domain |
| Q34474287 | Interaction and co-localization of JC virus large T antigen and the F-box protein β-transducin-repeat containing protein |
| Q28083455 | Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis |
| Q38739835 | Isolation and characterization of a novel putative human polyomavirus |
| Q41921811 | JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics |
| Q97418947 | JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review |
| Q34351212 | JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level |
| Q42203290 | JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity |
| Q38830062 | JC virus infection is acquired very early in life: evidence from a longitudinal serological study |
| Q33517629 | JC virus mediates invasion and migration in colorectal metastasis. |
| Q33582162 | JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity |
| Q35709154 | JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression |
| Q90333998 | JCPyV-Induced MAPK Signaling Activates Transcription Factors during Infection |
| Q35806533 | KI and WU polyomaviruses and CD4+ cell counts in HIV-1-infected patients, Italy |
| Q39939535 | Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. |
| Q42745441 | Lack of evidence for direct involvement of Merkel cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL). |
| Q39476021 | Latent viral infections in young patients with inflammatory diseases treated with biological agents: prevalence of JC virus genotype 2. |
| Q56795644 | Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients |
| Q33638470 | Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects |
| Q35804968 | Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada |
| Q38019683 | MCV and Merkel cell carcinoma: a molecular success story |
| Q34443783 | Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors |
| Q57064814 | Mechanisms of persistence by small DNA tumor viruses |
| Q45325990 | Merkel Cell Polyomavirus: A New DNA Virus Associated with Human Cancer |
| Q47658993 | Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics |
| Q37067101 | Merkel cell carcinoma: a virus-induced human cancer |
| Q42470781 | Merkel cell carcinoma: incidence, mortality, and risk of other cancers |
| Q36311177 | Merkel cell carcinoma: update and review |
| Q58724203 | Merkel cell polyomavirus and Langerhans cell neoplasm |
| Q34524022 | Merkel cell polyomavirus and trichodysplasia spinulosa-associated polyomavirus DNAs and antibodies in blood among the elderly |
| Q24633468 | Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin |
| Q38926910 | Merkel cell polyomavirus infection and Merkel cell carcinoma |
| Q38349670 | Merkel cell polyomavirus infection in childhood: current advances and perspectives. |
| Q37123294 | Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation |
| Q33966574 | Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens |
| Q35510910 | Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. |
| Q36468289 | Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential |
| Q33763571 | MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract. |
| Q59358029 | MicroRNAs as Potential Biomarkers in Merkel Cell Carcinoma |
| Q37261216 | Modulation of PML protein expression regulates JCV infection |
| Q35488123 | Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins. |
| Q41532326 | Molecular detection and characterization of BK and JC polyomaviruses in urine samples of renal transplant patients in Southern Brazil |
| Q42278777 | Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy |
| Q38610881 | Molecular insight into the viral biology and clinical features of trichodysplasia spinulosa |
| Q45400987 | Monitoring of KI and WU polyomaviruses in hematopoietic stem cell transplant patients |
| Q37968620 | Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis. |
| Q36418211 | Multiorgan WU Polyomavirus Infection in Bone Marrow Transplant Recipient |
| Q33781568 | Multiplex detection in tonsillar tissue of all known human polyomaviruses |
| Q36568666 | Natalizumab therapy for multiple sclerosis |
| Q39048568 | Natalizumab treatment of multiple sclerosis: new insights |
| Q37714089 | Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases |
| Q38221343 | Natalizumab: risk stratification of individual patients with multiple sclerosis |
| Q34380301 | Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy |
| Q26822247 | New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy |
| Q90325677 | Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis |
| Q34008597 | Newly described human polyomaviruses Merkel cell, KI and WU are present in urban sewage and may represent potential environmental contaminants |
| Q34203417 | Newly discovered KI, WU, and Merkel cell polyomaviruses: no evidence of mother-to-fetus transmission |
| Q35832335 | No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer |
| Q42246313 | No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV. |
| Q28389555 | Non-neoplastic and neoplastic pleural endpoints following fiber exposure |
| Q47552262 | Novel Human Polyomavirus non-coding control regions differ in bi-directional gene expression according to host cell, large T-antigen expression, and clinically occurring rearrangements |
| Q34789283 | Novel polyomaviruses of nonhuman primates: genetic and serological predictors for the existence of multiple unknown polyomaviruses within the human population |
| Q39751884 | Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma |
| Q38167687 | Oncogenic Papillomavirus and Polyomavirus in Water Environments: Is There a Potential for Waterborne Transmission? |
| Q37828002 | Pathogenesis of progressive multifocal leukoencephalopathy--revisited |
| Q36173844 | Patterns of polyomavirus SV40 infections and associated cancers in humans: a model |
| Q34459843 | Persistence and pathogenesis of the neurotropic polyomavirus JC |
| Q26751556 | Place of mTOR inhibitors in management of BKV infection after kidney transplantation |
| Q51706853 | Polyomavirus BK-specific CD8+ T cell responses in patients after allogeneic stem cell transplant. |
| Q34729712 | Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy |
| Q36408288 | Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. |
| Q40778451 | Polyomavirus and Naturally Occuring Neuroglial Tumors in Raccoons (Procyon Lotor). |
| Q39292843 | Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding |
| Q38205695 | Polyomavirus miRNAs: the beginning |
| Q35667349 | Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer |
| Q90725132 | Pre-Transplantation Assessment of BK Virus Serostatus: Significance, Current Methods, and Obstacles |
| Q33887689 | Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination. |
| Q94603267 | Presence of JC Polyomavirus in Nonneoplastic Inflamed Colon Mucosa and Primary and Metastatic Colorectal Cancer |
| Q40649540 | Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation. |
| Q37080822 | Prevalence of Merkel Cell Polyomavirus in Tehran: An Age-Specific Serological Study |
| Q58769497 | Prevalence of Respiratory Polyomaviruses Among Pediatric Patients With Respiratory Symptoms in Singapore |
| Q35736570 | Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast |
| Q40897816 | Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma |
| Q27678593 | Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding |
| Q35838586 | Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity |
| Q37798242 | Progressive multifocal leukoencephalopathy and newer biological agents |
| Q33506561 | Progressive multifocal leukoencephalopathy in HIV-1 infection |
| Q30778800 | Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review |
| Q45182536 | Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies? |
| Q92048780 | Promoter activity of Merkel cell Polyomavirus variants in human dermal fibroblasts and a Merkel cell carcinoma cell line |
| Q39371247 | Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma |
| Q21559417 | Quantitation of human seroresponsiveness to Merkel cell polyomavirus |
| Q40603173 | Re-detection vs. new acquisition of high-risk human papillomavirus in mid-adult women |
| Q37725435 | Reactivation of human polyomaviruses in immunocompromised states |
| Q41909038 | Replication of oral BK virus in human salivary gland cells |
| Q38001435 | Review on the relationship between human polyomaviruses-associated tumors and host immune system |
| Q39125214 | Review on the role of the human Polyomavirus JC in the development of tumors. |
| Q57623522 | Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab |
| Q36521237 | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| Q28538974 | Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease |
| Q37982013 | Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab |
| Q34120884 | Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. |
| Q90612176 | SV40 and human mesothelioma |
| Q38669190 | Safety of mTOR inhibitors in adult solid organ transplantation. |
| Q51863935 | Secondary lymphoid tissue as an important site for WU polyomavirus infection in immunocompetent children. |
| Q42720362 | Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. |
| Q34505098 | Seroepidemiology of Human Polyomaviruses in a US Population |
| Q37705552 | Seroepidemiology of human bocaviruses 1-4. |
| Q33591211 | Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses. |
| Q38104692 | Serological cross-reactivity between human polyomaviruses |
| Q34698094 | Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents. |
| Q36148032 | Seroprevalence and cross-reactivity of human polyomavirus 9. |
| Q34128714 | Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China |
| Q57799325 | Seroprevalence of fourteen human polyomaviruses determined in blood donors |
| Q34381176 | Seroprevalence of human Malawi polyomavirus |
| Q34204699 | Seroprevalence of trichodysplasia spinulosa-associated polyomavirus |
| Q39064776 | Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population. |
| Q41536196 | Serum antibodies from epileptic patients react, at high prevalence, with simian virus 40 mimotopes |
| Q46074542 | Shedding of polyomavirus in the saliva of immunocompetent individuals. |
| Q42181980 | Significant association between human osteosarcoma and simian virus 40. |
| Q34445195 | Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis |
| Q37641226 | Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme |
| Q35621800 | Simian virus 40 transformation, malignant mesothelioma and brain tumors |
| Q40222938 | Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy |
| Q35529977 | Small-molecule inhibitors of JC polyomavirus infection |
| Q64285968 | Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation |
| Q41544370 | Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression |
| Q35885632 | Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects. |
| Q45325212 | Specific Detection of Serum Antibodies against BKPyV, A Small DNA Tumour Virus, in Patients Affected by Choroidal Nevi |
| Q37681840 | Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera. |
| Q38822430 | Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population |
| Q37696800 | Structural evaluation of new human polyomaviruses provides clues to pathobiology |
| Q35229860 | Structural optimization of a retrograde trafficking inhibitor that protects cells from infections by human polyoma- and papillomaviruses. |
| Q27684639 | Structure Analysis of the Major Capsid Proteins of Human Polyomaviruses 6 and 7 Reveals an Obstructed Sialic Acid Binding Site |
| Q27665095 | Structure-Function Analysis of the Human JC Polyomavirus Establishes the LSTc Pentasaccharide as a Functional Receptor Motif |
| Q27680553 | Structures of B-Lymphotropic Polyomavirus VP1 in Complex with Oligosaccharide Ligands |
| Q27667695 | Structures of the Major Capsid Proteins of the Human Karolinska Institutet and Washington University Polyomaviruses |
| Q41927286 | Survey of KI, WU, MW, and STL Polyomavirus in Cancerous and Non-Cancerous Lung Tissues |
| Q50043312 | Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus. |
| Q34944346 | Synthesis and structure–activity relationships of small molecule inhibitors of the simian virus 40 T antigen oncoprotein, an anti-polyomaviral target |
| Q40365850 | Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum |
| Q28704590 | T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors |
| Q31032531 | T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles |
| Q35760458 | The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity |
| Q52641622 | The Human Polyomavirus Middle and Alternative T-Antigens; Thoughts on Roles and Relevance to Cancer. |
| Q39927510 | The Natural History of Human Polyomaviruses and Herpesviruses in Early Life--The Rhea Birth Cohort in Greece |
| Q90597125 | The Obesity-Related Gut Bacterial and Viral Dysbiosis Can Impact the Risk of Colon Cancer Development |
| Q36602362 | The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry |
| Q47548626 | The fate of urinary tract virus BK human polyomavirus in source-separated urine |
| Q38115572 | The human JC polyomavirus (JCPyV): virological background and clinical implications |
| Q37547573 | The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. |
| Q38115582 | The human polyomavirus BK (BKPyV): virological background and clinical implications |
| Q34351951 | The human polyomaviruses KI and WU: virological background and clinical implications |
| Q26859307 | The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy |
| Q37965603 | The link between VLA-4 and JC virus reactivation |
| Q39798753 | The minimum replication origin of merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication |
| Q34343557 | The novel human polyomaviruses HPyV6, 7, 9 and beyond |
| Q36295171 | The polyomaviruses WUPyV and KIPyV: a retrospective quantitative analysis in patients undergoing hematopoietic stem cell transplantation |
| Q34593626 | The raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumors |
| Q34629128 | The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology |
| Q30422891 | The role of infections and coinfections with newly identified and emerging respiratory viruses in children. |
| Q37061729 | The role of the immune response in merkel cell carcinoma |
| Q30617802 | The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications. |
| Q34972602 | Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes. |
| Q33763538 | Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts |
| Q64930981 | Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches. |
| Q53609248 | Treatment of pediatric multiple sclerosis. |
| Q34430041 | Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV |
| Q40571441 | Trichodysplasia spinulosa: A rare complication of immunosuppression |
| Q34110697 | Update on human polyomaviruses and cancer |
| Q91968612 | Viral replication centers and the DNA damage response in JC virus-infected cells |
| Q30384388 | Viruses and human cancers: a long road of discovery of molecular paradigms. |
| Q46002119 | Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients. |
| Q41488836 | WU and KI polyomavirus prevalence in invasive respiratory samples from transplant recipients in Cantabria, Spain |
| Q36318486 | WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients |
| Q34843445 | WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome |
| Q38084374 | Water quality indicators: bacteria, coliphages, enteric viruses |
| Q40758497 | Whole-genome characterization and genotyping of global WU polyomavirus strains |
| Q37811898 | Why do viruses cause cancer? Highlights of the first century of human tumour virology |
| Q83219527 | [Progressive multifocal leukoencephalopathy under natalizumab. Initial possibilities for risk stratification?] |
Search more.